Comparison of Antibody Response Elicited by ChAdOx1 and BNT162b2 COVID-19 Vaccine

BACKGROUND: ChAdOx1 and BNT162b2 vaccines are currently commonly used against coronavirus disease 2019 worldwide. Our study was designed to determine the serostatus and relative levels of anti-S and neutralizing antibodies in patients who were administered either ChAdOx1 or BNT162b2 vaccine. In addi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Yu Min, Minn, Dohsik, Lim, Jaegyun, Lee, Ki-Deok, Jo, Dong Ho, Choe, Kang-Won, Kim, Moon Jung, Kim, Jong Min, Kim, Kwang Nam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8629719/
https://www.ncbi.nlm.nih.gov/pubmed/34845875
http://dx.doi.org/10.3346/jkms.2021.36.e311

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8629719/
https://www.ncbi.nlm.nih.gov/pubmed/34845875
http://dx.doi.org/10.3346/jkms.2021.36.e311

Ejemplares similares